Amorepacific Unveils BluePDRN™ for Skin Health
Amorepacific's latest research has brought exciting insights into the world of skin regeneration and wound healing. The company has introduced 'BluePDRN™', a revolutionary product derived from microalgae that presents a sustainable alternative to traditional animal-derived polydeoxyribonucleotides (PDRNs).
The Rise of Microalgal-Derived PDRNs
PDRNs have gained popularity for their effectiveness in skin healing and rejuvenation. Traditionally extracted from animals like salmon, Amorepacific's shift to microalgal sources, specifically Chlorella protothecoides, underscores their commitment to sustainable practices.
Scientific Research at Play
This innovative research was spearheaded by Amorepacific's R&I Center as part of a collaborative initiative with the Ministry of Oceans and Fisheries. The goal was to explore marine materials' potential and develop a viable alternative in BluePDRN™. This product not only matches the efficacy of conventional PDRNs but also sets the stage for a groundbreaking production process that prioritizes sustainability.
The Mechanism Behind BluePDRN™
The study findings highlight that BluePDRN™ closely mimics the skin regeneration properties of its animal-derived counterparts. For instance, it was shown to achieve wound closure effects similar to those found with salmon-derived PDRN, albeit with molecules that are significantly smaller—about 1/20th the size, making them exceptionally versatile in skin applications.
Impacts on Skin Cell Functions
Research indicates that BluePDRN™ fosters collagen production and promotes angiogenesis, both crucial for maintaining healthy skin. Utilizing an adenosine A2A receptor (A2AR)-dependent pathway, BluePDRN™ reaffirms its regenerative benefits in various skin concerns, including damage from photoaging. These benefits were validated through experiments conducted by Outer Biosciences Inc., a firm dedicated to enhancing skin health.
Expert Insights and Future Directions
Byung-Fhy Suh, the Chief Technology Officer of Amorepacific's R&I Center, emphasized the significance of this research. He remarked, “This research showcases the value of plant-based PDRNs and underscores our commitment to safe and effective products worldwide.”
Innovation and Recognitions
Amorepacific's dedication to innovation is evident in their application for a patent regarding the production technology of BluePDRN™, which is a significant milestone in sustainable skincare. Furthermore, the company has earned accolades such as the New Excellent Technology (NET) certification and a commendation from the Ministry of Oceans and Fisheries, reflecting their commitment to excellence in dermatological science.
Frequently Asked Questions
What is BluePDRN™?
BluePDRN™ is a microalgal-derived polydeoxyribonucleotide developed by Amorepacific, aimed at enhancing skin regeneration and wound healing.
Why is BluePDRN™ considered sustainable?
It is sourced from Chlorella protothecoides, making it an animal-free alternative that supports eco-friendly practices.
What are the main benefits of BluePDRN™?
Research indicates it aids in wound healing, collagen production, and angiogenesis, crucial for skin health and regeneration.
How does BluePDRN™ compare to traditional PDRNs?
BluePDRN™ is smaller in molecular size and offers comparable efficacy without relying on animal sources.
What certifications has Amorepacific received for BluePDRN™?
Amorepacific has been awarded a New Excellent Technology (NET) certification and a minister's commendation for its advancements in this area.
